Catalyst Capital Advisors LLC Lowers Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Catalyst Capital Advisors LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 274 shares of the medical equipment provider’s stock after selling 57 shares during the quarter. Catalyst Capital Advisors LLC’s holdings in Intuitive Surgical were worth $135,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the business. Hazlett Burt & Watson Inc. boosted its holdings in Intuitive Surgical by 5.8% in the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after purchasing an additional 20 shares during the last quarter. Ullmann Wealth Partners Group LLC boosted its holdings in Intuitive Surgical by 1.6% in the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after purchasing an additional 21 shares during the last quarter. One Wealth Management Investment & Advisory Services LLC boosted its holdings in Intuitive Surgical by 3.4% in the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after purchasing an additional 23 shares during the last quarter. Daymark Wealth Partners LLC boosted its holdings in Intuitive Surgical by 0.3% in the third quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock valued at $3,452,000 after purchasing an additional 24 shares during the last quarter. Finally, Indiana Trust & Investment Management CO boosted its holdings in Intuitive Surgical by 5.3% in the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after purchasing an additional 25 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently issued reports on ISRG. Truist Financial increased their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their target price for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. Raymond James increased their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Piper Sandler reissued an “overweight” rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Trading Up 1.5 %

ISRG stock opened at $515.17 on Wednesday. The company has a market cap of $183.49 billion, a price-to-earnings ratio of 82.82, a PEG ratio of 4.98 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $269.49 and a 12 month high of $523.34. The firm has a 50-day moving average of $491.63 and a two-hundred day moving average of $449.59.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the sale, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Brian Edward Miller sold 2,553 shares of the firm’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the sale, the executive vice president now owns 7,066 shares of the company’s stock, valued at $3,638,990. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 68,246 shares of company stock worth $33,839,308. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.